期刊
HUMAN GENE THERAPY
卷 34, 期 7-8, 页码 259-272出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/hum.2022.235
关键词
viral vectors; AAV; gene therapy; biomanufacturing; training; short course
The manufacturing of gene therapy products is a rapidly growing industry due to its potential in treating rare and complex genetic diseases. However, there is a shortage of skilled staff in this field. To address this, more education and training opportunities are needed, such as the hands-on cGMP Biomanufacturing of Vectors for Gene Therapy course offered by BTEC at NC State.
The manufacturing of gene therapy products is a rapidly growing industry bolstered by the tremendous potential of these therapies to provide lifesaving treatment for rare and complex genetic diseases. The industry's steep rise has resulted in a high demand for skilled staff required to manufacture gene therapy products of the expected high quality. To address this skill shortage, more opportunities for education and training in all aspects of gene therapy manufacturing are needed. The Biomanufacturing Training and Education Center (BTEC) at the North Carolina State University (NC State) has developed and delivered (and continues to deliver) a 4-day, hands-on course titled Hands-on cGMP Biomanufacturing of Vectors for Gene Therapy. The course, which consists of 60% hands-on laboratory activities and 40% lectures, aims to provide a comprehensive understanding of the gene therapy production process, from vial thaw through the final formulation step, and analytical testing. This article discusses the design of the course, the backgrounds of the nearly 80 students who have participated in the seven offerings held since March 2019, and feedback from the course participants.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据